To Our Investors

Business objective of PSS is to contribute to early diagnosis and prevention of disease by providing easy-to-use healthcare systems in bio-field such as gene, protein or glycan, and ultimately to globally protect people's health through innovative diagnostic products. Our competence is in the technology of "automatization" and "sample preparation". The fully-automated nucleic acid extraction platforms and reagents which PSS uniquely developed are widely used in many of the genetic analysis laboratories worldwide through our business partners.

Our mission is not to develop and supply diagnostic reagent itself, but to continuously improve the quality and performance of diagnostic reagent through nucleic acid extraction technology and relevant products of high quality. Highly pure nucleic acid extracted with PSS technology enhances performance of diagnostic reagents and contributes to quality improvement and standardization of in-vitro diagnosis.

Recently, we keep eyes on glycan as a new marker of cancers and autoimmune disease. Glycan, another important molecule that supports life in addition to DNA (gene) and protein, plays quite an important role in conveying information between cells and diagnostic technology utilizing glycan is already a revolutionary method in early diagnosis of cancers or inflammatory disease.

PSS aims to support health and realize quality life of more people by offering innovative technology through reinforcement of partnership with our customers and suppliers.